Juliana Mulligan shares her transformative journey with the psychedelic ibogaine as a treatment that finally worked for her substance use disorder. She discusses her personal experiences with addiction, the limitations of traditional treatment methods, and the profound impact of trauma on recovery.

Juliana explains the unique experience of ibogaine treatment, its effects on brain chemistry, and the importance of post-treatment support. She addresses common misconceptions about ibogaine and emphasizes the need for thorough research when seeking treatment. The conversation highlights the potential of ibogaine as a powerful tool for healing and the promising future of its use in addiction treatment.

Links: 

About Juliana: 

Juliana Mulligan, LMSW, is a psychotherapist who is formerly opioid dependent, formerly incarcerated, and has been working in the ibogaine treatment community for thirteen years. In 2011, with the help of ibogaine treatment, Juliana left opioids behind and set off on a path to transform the way drug users and their treatment is approached. She has worked in multiple ibogaine clinics, was the Psychedelic Program Coordinator at the Center for Optimal Living, and was a consultant for the Kentucky Ibogaine Initiative. She currently runs Inner Vision Ibogaine, which supports clients in preparation and integration around ibogaine treatment and offers consulting services for those wishing to approach ibogaine through their projects. She is also the founder of Idryma, the first ibogaine treatment training and certification program. Juliana has presented at psychedelic and harm reduction conferences, is the author of the Guide to Finding a Safe Ibogaine Clinic, and co-author of Fireside’s Warning Signs When Selecting a Psychedelic Facilitator. She has taught about ibogaine at Charite University in Berlin and Southwestern College in New Mexico and has written for multiple publications about ibogaine, including Double Blind Magazine and Chacruna. Her quotes have been featured in the New York Times, Rolling Stone Magazine, National Geographic, and most recently she was mentioned on the Joe Rogan podcast. Her focus on abuse and ethics in the ibogaine treatment space has also led to her survivor advocacy and client support work with GITA and the Shine Collective.

Keywords: Ibogaine, addiction treatment, substance use disorder, psychotherapy, trauma, recovery, psychedelic therapy, mental health, neurochemistry, harm reduction

Prenatal substance use is often misunderstood, oversimplified, and met with stigma instead of support. In this conversation, Christina Dent and Meghann Perry explore the complex realities facing mothers who use substances during pregnancy—from trauma and addiction to healthcare barriers and the fear of criminalization. Together, they reflect on the importance of compassionate care, the power of bonding and attachment, and what it looks like to invest in families so both moms and babies can thrive. This episode invites us to move beyond judgment and toward curiosity, connection, and systems that heal rather than harm.

About Meghann:

Meghann Perry, CARC, RCPF, is an award-winning keynote speaker, storyteller, theatre educator, curriculum developer, harm reductionist and addiction recovery coach. She creates innovative learning experiences blending Theatre, Storytelling, and Coaching and is an international educator of the behavioral health workforce. Meghann is the author of two groundbreaking programs, Recovery Storytelling and Embodied Storytelling, and a global keynote speaker and presenter on peer support, storytelling, and stigma for organizations like NIH, NAADAC, FAVOR, PRCoE, HRSA, Hazelden, and the recent Lisbon Addictions Conference. Meghann is a person who used drugs who passionately supports people in prevention, harm reduction and recovery and leads a team of dedicated facilitators redefining education and intervention in the substance and mental health field. 

Links: 

Keywords: prenatal substance use, maternal health, addiction, recovery, healthcare, bonding, criminalization, compassionate care, systemic issues, early childhood trauma.

In this episode, Christina Dent and Bryan Mauk discuss the erosion of civil liberties due to drug policies, the implications of military actions against drug trafficking, and the ongoing debate surrounding substances like kratom and psychedelics. They explore how historical precedents in drug enforcement have led to current practices that compromise individual rights and question the effectiveness of aggressive interdiction strategies. 

Summary:

Sgt. Terry Blevins (Ret.) is a former law enforcement officer, the Law Enforcement Advisor to 7-HOPE Alliance, and a national security expert. He brings decades of experience in law enforcement, national security, and public safety. He began his career in Arizona law enforcement, later serving in the U.S. Department of Defense and State Department, where he advised governments on counter-terrorism and critical infrastructure protection. 

Keywords: drug policy, 7-OH, law enforcement, prohibition, pain management, advocacy, cannabis, opioid crisis, harm reduction, drug regulation

Could respect, not punishment, be the key to reducing harm from drugs and addiction?

Jim Babka, host of the Gracearchy podcast and Social Strategist for the Foundation for Harmony and Prosperty, joins Christina Dent to explain the Natural Principle of Human Respect. It's a simple but powerful idea that coercion always diminishes happiness, harmony, and prosperity.

Using lessons from the playground, flying cars, and even gravity, Jim shows how respecting others unlocks trust, community, and progress. From psychedelics to policy, he explains how force backfires and opportunities are lost when we ignore this principle.

This episode challenges us to rethink adult solutions by remembering the simple rules we practiced as kids, and to consider whether so many of our problems are caused by the fact that our laws are not consistent with what we learned on the playground. 

Resources:

Christina sits down with Dr. Michele Ross to talk about 7-OH, a new substance that’s closely connected to kratom. They unpack what it is, why people are using it, and what it could mean for pain management and addiction recovery. The conversation also looks at the FDA’s response, the push for medical freedom, and why education and responsible use matter so much with plant medicines like this one. They also explore the risks of banning substances and driving them into the underground market, where people lose access to safety and quality.

Resources:

7-HOPE Alliance Foundation: https://7hopealliance.org

Campaign to save 7OH - https://www.save7oh.org/

Dr Ross' book Kratom Is Medicine (2021): https://a.co/d/1Dw0dRh

What does it take to build a thriving legal marijuana market?

Christina Dent and Bryan Mauk sit down with Geoffrey Lawrence, Research Director at the Reason Foundation, to explore the economic lessons from cannabis legalization across the United States.

Drawing on his unique experience as a researcher and a CFO in the marijuana industry, Geoff explains how smart regulation can undercut the black market, foster innovation, and create healthier communities.

They discuss the evolution of cannabis laws, what motivates legalization, and how future policy could open the door to interstate commerce, new products, and stronger legal markets.

Links:

The war on drugs is not just affecting the US population. In this episode, we're joined by Franco Iacomini, Latin America editor at Christianity Today, to discuss his recent article on how cartel violence is impacting churches in Mexico. In many rural communities, children are forcibly recruited into cartels, and for some, drug trafficking becomes the only viable path to economic survival.

What if prisons focused less on punishment and more on healing? In this episode, Brian Koehn shares his journey from overseeing 65 prisons to launching the world’s first full-service nonprofit prison model. He explains why a human-centered approach could transform corrections, and why it’s time we expect more from our corrections system.